The Canadian Natural Health Products Directorate (NHPD) has granted Frutarom a product license for its Benolea cardiovascular health support ingredient.
The ingredient supports cardiovascular health by maintaining healthy blood pressure levels.
A recent clinical study by Endang Susalit, PhD, et al, showed that extract of olive leaf (Olea europaea) was effective in patients with stage-1 hypertension, demonstrating that Benolea can lower blood pressure.
Benolea, manufactured in Wadinswil, Switzerland, using Frutarom’s proprietary HyperPure process, will be available to local dietary supplement manufacturers in Canada next month.
Benolea will be marketed in Canada by CK Ingredients, an Ontario, Canada-based distributor of specialty food and supplement ingredients.
According to The Heart and Stroke Foundation, research affirms that heart/cardiovascular disease is the number one killer in Canada.
It also is the most costly disease in the country, placing the greatest burden on the national health care system.
Based on the latest available heart disease and stroke statistics, about 40% of Canadians have high blood cholesterol (Statistics Canada, 2012), and nearly 20% of Canadian adults (about six million) have high blood pressure.
Since ancient times, olive leaves have been used for medicinal purposes, exhibiting a wide range of activity, especially for cardiovascular health.
The company says Benolea offers the health benefit of olive leaves in a very convenient form for dietary supplement manufacturers.
